B Braun Company Profile

✉ Email this page to a colleague

What is the competitive landscape for B BRAUN, and what generic alternatives to B BRAUN drugs are available?

B BRAUN has one hundred and seventeen approved drugs.

There are two US patents protecting B BRAUN drugs.

There are twenty-seven patent family members on B BRAUN drugs in twenty-seven countries and two hundred and thirty-six supplementary protection certificates in sixteen countries.

Summary for B Braun

International Patents:	27
US Patents:	2
Tradenames:	225
Ingredients:	63
NDAs:	117

Drugs and US Patents for B Braun

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
B Braun	DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	019631-013	Feb 24, 1988		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun	DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER	dextrose; sodium chloride	INJECTABLE;INJECTION	019631-014	Feb 24, 1988		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun	GENTAMICIN SULFATE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER	gentamicin sulfate	INJECTABLE;INJECTION	062814-003	Aug 28, 1987		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun	AMMONIUM CHLORIDE 2.14%	ammonium chloride	INJECTABLE;INJECTION	085734-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun	POTASSIUM CHLORIDE 0.075% IN DEXTROSE 5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER	dextrose; potassium chloride; sodium chloride	INJECTABLE;INJECTION	019630-002	Feb 17, 1988		RX	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun	FREAMINE III 8.5% W/ ELECTROLYTES	amino acids; magnesium acetate; phosphoric acid; potassium acetate; potassium chloride; sodium acetate	INJECTABLE;INJECTION	016822-007	Jul 1, 1988		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
B Braun	SODIUM CHLORIDE 0.9% AND POTASSIUM CHLORIDE 0.22% IN PLASTIC CONTAINER	potassium chloride; sodium chloride	INJECTABLE;INJECTION	018722-003	Nov 9, 1982		DISCN	No	No		⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for B Braun

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
B Braun	HEPATAMINE 8%	amino acids	INJECTABLE;INJECTION	018676-001	Aug 3, 1982	3,950,529	⤷ Try a Trial
B Braun	UCEPHAN	sodium benzoate; sodium phenylacetate	SOLUTION;ORAL	019530-001	Dec 23, 1987	4,284,647	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for B Braun Drugs

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Estimated Expiration
Philippines	12015501313	⤷ Try a Trial
Russian Federation	2015128024	⤷ Try a Trial
Cyprus	1114743	⤷ Try a Trial
Croatia	P20131221	⤷ Try a Trial
New Zealand	709631	⤷ Try a Trial
China	105283222	⤷ Try a Trial
South Korea	20150085131	⤷ Try a Trial
>Country	>Patent Number	>Estimated Expiration

Supplementary Protection Certificates for B Braun Drugs

Subscribe to access the full database, or Try a Trial
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0484186	1190033-9	Sweden	⤷ Try a Trial	PRODUCT NAME: 4-AMINOPYRIDIN ELLER ETT SALT DAERAV; REG. NO/DATE: EU/1/11/699/001 20110720
0186405	SPC/GB00/021	United Kingdom	⤷ Try a Trial	PRODUCT NAME: (1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE)BIS(PHOSPHONIC ACID) "RESIDRONATE" AND SALTS THEREOF, ESPECIALLY THE SODIUM SALT; REGISTERED: SE 15296 19991007; SE 15297 19991007; UK PL 00364/0070 20000316
0933372	13/2008	Austria	⤷ Try a Trial	PRODUCT NAME: FOSAMPRENAVIR ALS FOSAMPRENAVIR-CALCIUM; REGISTRATION NO/DATE: EU/1/04/282/001 - EU/1/04/282/002 (MITTEILUNG VOM 14.07.2004) 20040713
0812190	SPC/GB05/042	United Kingdom	⤷ Try a Trial	PRODUCT NAME: MESYLATE, ESYLATE OR SULFATE SALTS OF N-PROPARGYL-1(R)-AMINOINDAN (RASAGILINE); REGISTERED: UK EU/1/04/304/001 20050221; UK EU/1/04/304/002 20050221; UK EU/1/04/304/003 20050221; UK EU/1/04/304/004 20050221; UK EU/1/04/304/005 20050221; UK EU/1/04/304/006 20050221; UK EU/1/04/304/007 20050221
2932970	18C1043	France	⤷ Try a Trial	PRODUCT NAME: UNE COMBINAISON COMPRENANT DU DOLUTEGRAVIR OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI,EN PARTICULIER LE SEL DE SODIUM DU DOLUTEGRAVIR,ET DE LA RILPIVIRINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELLE-CI,EN PARTICULIER LE CHLORHYDRATE DE RILPIVIRINE; REGISTRATION NO/DATE: EU/1/18/1282 20180518
1718641	SPC/GB12/028	United Kingdom	⤷ Try a Trial	PRODUCT NAME: AZILSARTAN MEDOXOMIL AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, INCLUDING THE POTASSIUM SALT; REGISTERED: UK EU/1/11/734/001-011 20111209
0720599	300689	Netherlands	⤷ Try a Trial	PRODUCT NAME: EZETIMIBE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, EN ATORVASTATINE, DESGEWENST IN DE VORM VAN EEN FARMACEUTISCH AANVAARDBAAR ZOUT, IN HET BIJZONDER ATORVASTATINE CALCIUM TRIHYDRATE; NATIONAL REGISTRATION NO/DATE: RVG114373-114376 20141027; FIRST REGISTRATION: FR 2014091200122 20140912
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Summary for B Braun

Similar Applicant Names

Make Better Decisions: Try a trial or see plans & pricing